您现在的位置: 首页> 研究主题> 抗原表达

抗原表达

抗原表达的相关文献在1988年到2022年内共计259篇,主要集中在肿瘤学、内科学、基础医学 等领域,其中期刊论文171篇、会议论文16篇、专利文献38124篇;相关期刊132种,包括中华病理学杂志、中华临床医师杂志(电子版)、传染病信息等; 相关会议14种,包括中华医学会临床输血学分会第一届学术年会、浙江省毒理学会第一届学术年会暨食品药品与人类健康论坛、中国老年学学会老年肿瘤专业委员会(CGOS)2014年年会暨第八届中国老年肿瘤学大会等;抗原表达的相关文献由708位作者贡献,包括吴金龙、张伟、邓秀新等。

抗原表达—发文量

期刊论文>

论文:171 占比:0.45%

会议论文>

论文:16 占比:0.04%

专利文献>

论文:38124 占比:99.51%

总计:38311篇

抗原表达—发文趋势图

抗原表达

-研究学者

  • 吴金龙
  • 张伟
  • 邓秀新
  • 马兆成
  • 仲西城太郎
  • 安德烈亚斯·特斯
  • 托马斯·施拉克
  • 日比野利彦
  • 片桐千华
  • 约亨·普罗布斯特
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 仲华; 林志强; 王亚南; 王志银; 杨晓冬; 张青宜; 王朝辉
    • 摘要: 目的 探讨急性早幼粒细胞性白血病(APL)以外的急性白血病(AL)患者抗原表达差异性分析及对疗效的影响.方法 流式细胞术检测158例APL以外的AL患者[急性淋巴细胞白血病(ALL)28例,急性髓细胞白血病(AML)组32例]的抗原阳性表达率,分析其对疗效的影响.结果 ALL中CD13、CD33阳性表达率无差异(P>0.05);AML中CD3、CD10阳性表达率高于其他抗原阳性表达率(P<0.05).ALL化疗后有60例完全缓解;AML化疗后有67例完全缓解.ALL和AML患者中,3~5个疗程内缓解、部分缓解及未缓解者抗原阳性表达率与2个疗程内缓解者抗原阳性表达率比较均有显著差异(P<0.05).结论 急性非APL白血病患者抗原表达差异性对疗程缓解率预测有重要价值,可作为疗效判断的特异性分析.
    • 刘璐洁; 刘妍; 杨悦; 余双庆; 许智慧; 赵丽; 刘新光; 吴小兵; 徐东平; 董小岩
    • 摘要: 目的 建立高嗜肝性重组8型腺相关病毒(recombinant adeno-associated virus 8,rAAV8)介导的C基因型多重耐药乙型肝炎病毒(multidrug resistant hepatitis B virus,MDR HBV)稳定复制表达小鼠模型.方法 分别构建rAAV8-1.3倍C基因型多重耐药型(HBV逆转录酶区含有rtL180M+S202G+M204V+N236T位点)和野生型HBV重组质粒,然后包装纯化并筛选高滴度重组病毒(rAAV8-1.3HBV-C-MDR和rAAV8-1.3HBV-C-WT),将病毒经尾静脉注射至6~8周龄的C57BL/6小鼠,建立C基因型多重耐药型(实验组,n=6)和野生型(对照组,n=6)HBV稳定复制表达小鼠模型,监测病毒复制和抗原表达至9周并于第9周末处死小鼠,取肝脏组织进行HE染色和免疫组化染色,观察肝组织病理改变并分析HBsAg和HBcAg的表达.结果 小鼠注射重组病毒后第2、3、5、7、9周,血清HBV DNA表达较稳定,实验组和对照组小鼠血清HBV DNA波动范围分别为3.67~4.06 lg IU/ml和4.36~5.11 lg IU/ml.血清HBsAg和HBeAg在观察期间均高表达,第2周实验组和对照组血清HBsAg和HBeAg OD值分别为3.501±0.230和2.989±0.250,3.967±0.230和3.384±0.230.2组小鼠肝组织未见明显的炎性细胞浸润及组织结构异常,但可检测到HBsAg和HBcAg蛋白表达.结论 利用高嗜肝性rAAV8载体携带1.3倍C基因型MDR HBV基因组体内转导C57BL/6小鼠,成功建立了稳定复制并持续表达C基因型MDR HBV的小鼠模型,为后续评价抗MDR HBV药物疗效提供实验平台.
    • 宫文玉; 倪良胜; 林春
    • 摘要: 目的 探讨CD56抗原与老年急性髓系白血病患者疗效及预后的相关性.方法 选取138例老年急性髓系白血病患者进行前瞻性研究,根据CD56抗原表达情况分为阳性组(74例)与阴性组(64例).所有患者治疗方案均为蒽环类药物联合阿糖胞苷,比较阳性组与阴性组患者的完全缓解率、无病生存时间(DFS)、总生存时间(OS)、3年DFS率与3年OS率,对CD56抗原表达与患者DFS、OS进行相关性分析.结果 阳性组与阴性组患者的完全缓解率分别为86.49%、93.75%,差异无统计学意义(χ2=0.993,P=0.319).阳性组DFS与OS分别为(1.64±0.57)年、(2.70±0.81)年,均短于阴性组(t=2.026,P=0.047;t=2.050,P=0.044),3年DFS率与OS率分别为22.22%、38.89%,均低于阴性组(χ2=4.600,P=0.032;χ2=4.848,P=0.028).CD56抗原表达与DFS(r=0.425,P=0.002)、OS(r=0.557,P=0.000)均有显著正相关,与复发情况之间呈显著负相关(r=-0.756,P=0.001),阳性患者的复发风险更大.结论 CD56抗原表达与老年急性髓系白血病患者预后之间存在明显相关性,表现为CD56抗原阳性患者DFS与OS短于阴性患者,复发率更高.%Objective To investigate the correlation between CD56 antigen and the prognosis and prognosis of elderly patients with acute myeloid leukemia. Methods 138 elderly patients with acute myeloid leukemia were selected,and divided into positive group (74 cases)and negative group (64 cases)according to the CD56 antigen expression. All patients were treated with anthracycline combined with cytarabine. The complete remission rate,disease - free survival time (DFS),total survival time (OS),3 - year DFS rate and 3 - year OS rate were compared be-tween the positive group and the negative group,the correlation of the expression of CD56 antigen with DFS and OS in patients were analyzed. Re-sults The complete remission rate of positive and negative group was 86. 49% and 93. 75%,the difference was not statistically significant (χ2 =0. 993,P = 0. 319). The DFS and OS in positive group were (1. 64 ± 0. 57)years,(2. 70 ± 0. 81)years,which were shorter than those in the negative group (t = 2. 026,P = 0. 047;t = 2. 050,P = 0. 044). The 3 years DFS rate and OS rate in positive group were 22. 22%,38. 89%, which were lower than those in negative group (χ2 = 4. 600,P = 0. 032;χ2 = 4. 848,P = 0. 028). The expression of CD56 antigen was signifi-cantly positive correlated with DFS (r = 0. 425,P = 0. 002)and OS (r = 0. 557,P = 0. 000),and there was a significant negative correlation with recurrence (r = - 0. 756,P = 0. 001),the patients CD56 positive expression were easier to relapse. Conclusion There is a significant correlation between the expression of CD56 antigen and the prognosis of elderly patients with acute myeloid leukemia. The DFS and OS of CD56 antigen positive patients are shorter than those of negative patients,and the recurrence rate is higher.
    • 王荣芋; 张小楠; 张占卿; 陆伟; 沈芳; 冯艳玲; 袁正宏
    • 摘要: Objective To inquire into the influences of androgen receptor (AR)and estrogen-α(ERα)in liver tissue in patients with chronic hepatitis B (CHB)on HBV DNA and HBsAg level in serum,and HBsAg and HBcAg expression level in liver tissue. Methods 135 patients with CHB were enrolled in present study,in which 80 patients and 55 patients respectively were HBeAg-positive and HBeAg-negative. AR mRNA and ERαmRNA in liver tissue were assayed by reverse quantitative PCR. Results In HBeAg-positive patients,serum HBV DNA level was not correlated significantly with both AR mRNA and ERαmRNA level in liver tissue(r= 0.132,P= 0.241 和r= 0.130,P= 0.249),and serum HBsAg level was positively correlated significantly with both AR mRNA and ERαmRNA level in liver tissue(r= 0.355,P= 0.001 和r=0.246,P= 0.028);HBcAg expression level in liver tissue was positively correlated significantly with both AR mRNA and ERαmRNA level in liver tissue(rs= 0.438,P= 0.000 和rs= 0.352,P= 0.002),,and HBsAg expression level in liver tissue was not correlated significantly with both AR mRNA and ERαmRNA level in liver tissue(rs= 0.112,P= 0.333 和rs= 0.024,P= 0.836). In HBeAg-negative patients,serum HBV DNA level was not correlated significantly with both AR mRNA and ERαmRNA level in liver tissue (r= -0.256,P= 0.061 and r= -0.121,P= 0.385),and serum HBsAg level was not correlated significantly with both AR mRNA and ERαmRNA level in liver tissue (r= 0.130,P= 0.348 and r= 0.165,P= 0.234);HBcAg expression level in liver tissue was not correlated significantly with both AR mRNA and ERαmRNA level in liver tissue (rs= -0.053,P= 0.701 and rs= -0.203,P= 0.137),and HBsAg expression level in liver tissue was not correlated significantly with both AR mRNA and ERαmRNA level in liver tissue (rs= 0.159,P=0.247 and rs= 0.192,P= 0.160).The outcomes of multivariate analyses of variance and ordinal logistic regression analyses showed that AR mRNA level in liver tissue was the independent factor influencing HBsAg level in serum and HBcAg expression level in liver tissue. Conclusion AR level in liver tissue is an independent factor influencing antigen expression of hepatitis B virus in patients with CHB.%目的:探讨肝组织内雄激素受体(AR)和雌激素受体-α(ERα)含量对慢性乙型肝炎(CHB)患者血清 HBV DNA载量、HBsAg水平和肝组织内 HBsAg、HBcAg表达水平影响。方法135例经肝活组织检查的CHB患者入选本研究,其中 HBeAg阳性80例,HBeAg阴性55例。肝组织内AR mRNA和ERαmRNA采用反转录定量PCR检测。结果 HBeAg阳性患者,血清HBV DNA载量与肝组织内AR mRNA和ERαmRNA含量均无显著相关性(r=0.132,P=0.241和r=0.130,P=0.249),血清 HBsAg 水平与肝组织内 AR mRNA 和 ERαmRNA 含量均呈显著正相关(r=0.355,P=0.001和r=0.246,P=0.028);肝组织内 HBcAg 表达水平与肝组织内AR mRNA和 ERαmRNA 含量均呈显著正相关(rs=0.438,P=0.000和rs=0.352,P=0.002),肝组织内 HBsAg 表达水平与肝组织内AR mRNA和ERαmRNA含量无显著相关性(rs=0.112,P=0.333和rs=0.024,P=0.836)。HBeAg 阴性患者,血清 HBV DNA载量与肝组织内AR mRNA和ERαmRNA含量均无显著相关性(r=-0.256,P=0.061和r=-0.121,P=0.385),血清HBsAg水平与肝组织内AR mRNA和ERαmRNA含量均无显著相关性(r=0.130,P=0.348和r=0.165,P=0.234);肝组织内 HBcAg表达水平与肝组织内AR mRNA和ERαmRNA含量均无显著相关性(rs=-0.053,P=0.701和rs=-0.203,P=0.137),肝组织内 HBsAg表达水平与肝组织内AR mRNA和ERαmRNA含量无显著相关性(rs=0.159, P=0.247和rs=0.192,P=0.160)。多因素方差分析和有序Logistic 回归分析的结果显示,肝组织内AR mRNA 为影响HBeAg阳性患者血清 HBsAg水平和肝组织内 HBcAg表达水平的独立因素。结论肝组织内AR表达水平是影响CHB患者 HBV抗原表达的一个独立因素。
    • 李亚萍; 莫志贤; 曹露晔
    • 摘要: 目的 观察化香树果序对EB病毒壳抗原表达的影响及对人鼻咽癌CNE2细胞的细胞毒作用.方法 用间接免疫酶法测定化香树果序对B95-8细胞病毒壳抗原(virus capsid antigen,VCA)表达的影响;用MTT法测定其对人鼻咽癌CNE2细胞的细胞毒作用.结果 化香树果序在无毒浓度下对正丁酸钠激发的B95-8细胞EB病毒VCA表达有明显抑制作用;在高浓度时对人鼻咽癌细胞CNE2的生长有较强抑制作用.结论 化香树果序能抑制EB病毒抗原的表达,对人鼻咽癌CNE2细胞具细胞毒作用,值得进一步研究.
    • 樊都; 吴勇
    • 摘要: 目的:探讨CD11b在慢性阻塞性肺疾病患者中的表达改变与免疫功能改变关系。方法研究纳入都江堰市人民医院COPD患者10例(年龄60.12±7.10),非COPD患者10例(61.12±7.11)作为对照组。利用外周血2ml,进行羟基淀粉分离白细胞,孵育中性粒细胞CD抗原的抗体。用流式细胞仪(Flow Cytometry)检测样品。测得抗原标记的目标细胞数和抗原表达强度。统计资料通过SPSS 17软件包完成。对COPD与非COPD进行方差分析。结果 COPD患者成熟粒细胞表面抗原CD11b表达强度与非COPD患者比较中达到了统计学意义(P=0.012)。结论本研究发现COPD患者CD11b表达较非COPD患者CD11b表达强度高,提示与COPD患者免疫功能改变有关。%OBJECTIVE: To explore the ralationship of CD11b exprssion and the immunologic function in the chronic obstructive pulmonary disease.METHODS: The 10 COPD patients(age 60.12±7.10)and10 non-COPD patients (age 61.12±7.11) from the medical ward of Dujiangyan republic hospital,.The leukocytes were separated with hydroxyl starch form 2ml peripheral venous blood. The CD 11b antigen of granulopoesis were incubated with fluorescence-labeled CD antibodies. Samples were detected by flow cytometry. Al statistical data were completed by SPSS 17 package. Using variance analysis, COPD patients, non-COPD patients were compared between groups.RESULTS: There has a notable statistical significance of the expressive fluorescence intensity of CD11b antigen bewteen COPD group and control group(P=0.012).Conclusion:The expressive fluorescence intensity of CD11b antigen of COPD patients was higher;It suggests that the COPD patients have changed in immune function.
    • 陈红梅; 齐曼; 夏成青; 孙晓柏; 陈杭; 信亚文
    • 摘要: 目的 比较成熟T细胞肿瘤与T细胞反应性增生白细胞共同抗原CD45、全T细胞抗原CD2、CD3、CD5、CD7及CD4、CD8等的表达差异,探讨上述抗原表达变化在成熟T细胞肿瘤诊断中的价值.方法 对36例成熟T细胞肿瘤及36例T细胞反应性增生流式细胞免疫分型资料进行回顾性分析.根据抗原表达及其与正常T细胞的比较,将T细胞抗原表达模式分为抗原丢失及抗原强度变化.强度变化包括表达减弱、表达增强、双峰表达、表达不均匀等.结果 63.9%的成熟T细胞肿瘤有1项或多项全T细胞抗原丢失(23/36),明显高于对照组的8.3%(3/36),两者差异具有显著性(χ2=21.772,P<0.0001).36.1%的成熟T细胞肿瘤病例有3项或4项全T抗原强度变化(13/36),明显高于对照组的8.3%(3/36).两者差异具有显著性(χ2=6.525,P=0.0106).97.2%的成熟T细胞肿瘤CD4/CD8比例异常(35/36),明显高于对照组的22.2%(8/36),两者差异具有显著性(χ2=39.024,P<0.0001).27.8%的成熟T细胞肿瘤CD45表达异常(10/36),明显高于对照组的2.8%(1/36),两者差异具有显著性(χ2=6.859,P<0.0088).结论 成熟T细胞肿瘤与T细胞反应性增生在全T细胞抗原、CD4、CD8及CD45表达方面具有明显不同的特点,上述抗体的检测有助于成熟T细胞肿瘤的诊断及鉴别诊断.%Objective To explore ihe value of deleclion of leucocyle common anligen CD45, pan-T cell anligen CD2, CD3 , CD5 , CD7 and T cell subsels anligen CD4 and CD8 in ihe diagnosis of malure T cell neoplasm by comparing ihe expression profiles of above anligens in malure T cell neoplasm and reaclive T cell hyperplasia. Methods Thirty six cases of malure T-cell neoplasm and 36 reaclive T cell hyperplasia wilh mulliparameler flow immunophenolye were relrospeclively analyzed. The expression pallerns of anligens were classified as loss of anligen, and abnormal inlensily of anligen expression including down regulation, up regulation, bimodal and helerogeneily. Results 63. 9% of malure T cell neoplasm losl one or more pan-T anligens (23/36) , while only 8. 3% cases of conlrol group losl one pan-T anligen( 3/36 ) . The difference was slalislically significant x =21. 772, P < 0. 0001) . The percentage of malure T cell neoplasm showing 3 or 4 abnormal inlensily of pan-T anligens was up lo 36. 1% (16/ 36) , which was significantly higher lhan thai of conlrol cases ( 8. 3% , 3/36; x2 = 6. 525 , P = 0. 0106 ) . Abnormal CD4/CD8 ralio was delecled in 97. 2% of malure T cell neoplasm showing( 35/36) , however only 22. 2% of conlrol cases showing abnormal CD4/CD8 ralio ( 3/36 ) ( x2 = 39. 024, P < 0. 0001 ) . The percentage of malure T cell neoplasm showing abnormal expression of CD45 was significantly higher lhan thai of conlrol group(27. 8% vs. 2. 8% ; x2 =6. 859, P < 0. 0088 ) . Conclusions Malure T cell neoplasm is differenl from reaclive T cell hyperplasia in expression of pan-T anligen,CD4,CD8 and CD45. Deleclion of above anligen expression is helpful in ihe diagnosis of malure T cell neoplasm.
    • 宋福杰; 刘相燕; 王洲
    • 摘要: Objective To detect the expression of classical human leukocyte antigen (HLA) class Ⅰ antigens in primary lesions and metastatic lymph nodes in non-small cell lung cancer (NSCLC) by using flow cytometry (FCM),elucidate the correlation of classical HLA class Ⅰ antigen expression with primary lesions and metastatic lesions,and probe the relationship between loss of transporter associated with antigen processing 1 ( TAP1 ),latent membrane protein 2 ( LMP2 ) mRNA and loss or down-regulated classical HLA class Ⅰ antigen expression in tumorcells.Methods The expression of classical HLA class Ⅰ antigens in 65 primary lesions in NSCLC and 31 metastatic cancer lesions in lymph nodes was examined by FCM.The expression of TAP1 and LMP2 mRNA in 31 primary lesions in NSCLC with classical HLA- Ⅰ antigens downregulation or loss and 31 metastatic lesions in lymph nodes with down-regulation or loss of HLA-Ⅰ antigens was detected by using reverse transcription-polymerase chain reaction ( RT-PCR).Results The expression rate of classical HLA class Ⅰ antigens in 31 lymph node metastatic lesions [ (15.35 ±6.24)%] was remarkably lower than that in primary lesions [ (39.68 ± 12.46)%] (t =2.06,P<0.05 ),and positive correlation existed between down-regulated classical HLA class Ⅰ antigens in primary lesions in NSCLC with metastatic lesions in lymph nodes (rs =0.487,P <0.01 ).The expression of TAP1 and LMP 2 mRNA was detected in 13 cases (41.9%) and 12 cases (38.7%) in 31 primary lesions,and 5 cases (16.1% ) and 4 cases ( 12.9% ) in 31 metastatic lesions,respectively.There was significant difference in the expression of TAP1 and LMP 2 mRNA between primary lesions and metastatic lesions ( P < 0.05 ).Conclusion There is a positive correlation between the expression of classical HLA class Ⅰantigens in primary lesions in lung cancer and metastatic lesions in lymph nodes.Loss or down-regulation of classical HLA class Ⅰ antigen expression in primary lesions is one of mechanisms of cancer metastasis to lymph nodes in NSCLC.Negative expression of TAP1 and LMP2 mRNA is one of mechanisms of classical HLA- Ⅰ antigens loss or down-regulation in primary lesions and metastatic lesions of NSCLC.%目的 探讨非小细胞肺癌( NSCLC)经典人类白细胞抗原Ⅰ(HLA-Ⅰ)类抗原表达下调与淋巴结癌转移的相关性及其调控机制.方法 应用流式细胞术检测65例NSCLC原发灶及31例淋巴结转移灶经典HLA-Ⅰ类抗原的表达,应用逆转录-聚合酶链反应(RT-PCR)技术检测各31例非小细胞肺癌原发灶、淋巴结转移灶抗原处理相关转运体1 (TAP1) mRNA、潜伏膜蛋白2(LMP2)mRNA的表达,根据不同的变量类型及目的,采用不同的统计方法分析.结果 淋巴结转移灶经典HLA-Ⅰ类抗原的表达率(15.35 ±6.24)%明显低于肺癌原发灶(39.68 ±12.46)%(t=2.06,P<0.05),且与肺癌原发灶经典HLA-Ⅰ类抗原表达下调明显呈正相关(rs=0.487,P<0.01).经典HLA-Ⅰ类抗原表达下调与阳性表达的肺癌原发灶TAP1 mRNA、LMP2mRNA表达率差异有统计学意义(P<0.05).经典HLA-Ⅰ类抗原表达下调的淋巴结癌转移灶中TAP1 mRNA、LMP2 mRNA表达率明显低于肺癌原发灶(X2=5.01及5.39,P<0.05).结论 经典HLA-Ⅰ类抗原表达下调是肺癌淋巴结转移的机制之一.TAP1、LMP2 mRNA的表达缺陷是NSCLC原发灶及淋巴结转移灶经典HLA-Ⅰ抗原表达下调的机制之一,在淋巴结癌转移灶表现更明显.
    • 张瑛; 邹和群; 夏学颖
    • 摘要: 目的 观察改良酶消化法分离、培养人脐静脉内皮细胞(human umbilial vein endothelial cells,HUVECs)的效果,探讨获取高纯度、高活性HUVECs的培养方法.方法 采集健康新生儿脐带,应用改良的酶消化法(含0.016% EDTA的0.25%胰蛋白酶)进行HUVECs的分离培养;通过细胞形态学观察及免疫荧光化学鉴定HUVECs及其特异性抗原的表达.结果 体外培养的HUVECs细胞形态呈铺路石样,Ⅷ因子相关抗原荧光染色阳性,细胞纯度可达99%.结论 通过本实验改良的分离培养方法,可以在体外获得较高数量的HUVECs,在细胞形态、表面抗原标志等方面具内皮细胞特征,可以用于血管内皮细胞模型的构建.%Objective To explore an efficient method for culturing and purifying human umbilial vein endothelial cells (HUVECs) in vitro. Methods HUVECs from human umbilical cords were isolated and cultured by modified enzyme digestion technique (0. 25% trypsin containing 0.016% EDTA). HUVECs were observed under inverted microscope and identified by immunofluorescence . Results The endothelial cells arrayed like pitching stone under light microscopy . Factor Ⅷ in the Ecs showed positive by immunohisto — chemistry with cell purity >99%. Conclusion This method yields a large amount of viable HUVECs with typical endothelial charac — teristics and high survival rate , and can be used to construct the vascular endothelial cell model .
    • 沈福晓; 蒋金凤; 程安春; 汪铭书; 路立婷; 贾仁勇; 朱德康; 陈孝跃; 孙涛
    • 摘要: [Objective] DNA-chitosan nanoparticles carrying duck plague vims (DPV) gC gene were constructed by using complex coacervation process to investigate its antigenic expression and distribution in the vaccinated ducklings. [ Method ] The 20-day-old DPV-free ducklings were respectively immunized with chitosan/pcDNA-DPV-gC gene vaccine via intramuscular injection, nasal administration and oral administration. At intervals of 4 h, 12 h, 1 d, 3 d, 5 d, 7 d, 2 w, 4 w, 6 w and 10 w post-vaccination (p.v.), two ducklings were randomly euthanatized and their organs (liver, spleen, lung, kidney, pancreas, brain, thymus, Harderian gland, bursa of Fabricius, esophagus, duodenum, caecum, and rectum) were collected. Meanwhile, an indirect itnmunohistochemical staining (IHC) was developed to detect antigenic expression and distribution of DPV gC antigens in the vaccinated ducklings. [Result] The DPV gC proteins were found in the liver, bursa of Fabricius, duodenum, caecum and rectum in the intramuscular injection group at 1 d post-vaccination (p.v.); Moreover, the immunogenicity were firstly found in the lung at 12 h p.v., and the DPV gC proteins were observed in the bursa of Fabricius and Harderian gland in the nasal administration group at 1 d p.v. Furthermore, the positive signals were firstly found in the esophagus at 12 h p.v., and the DPV gC proteins were observed in the bursa of Fabricius, duodenum, caecum and rectum in the oral administration group at 1 d p.v.. The DPV gC proteins were distributed in the liver, lung, bursa of Fabricius, Harderian gland, esophagus, duodenum, caecum and rectum, which were served as the principal sites for DPV gC antigens localization. The positive immunogenicity was mainly distributed in the parenchymal hepatic cells, epithelial cells of lung, lymphocytes of Harderian gland and bursa of Fabricius, epithelial cells of esophagus, epithelial cells and lamina propria mucosae cells of intestinal tract. According to the immunogenicity intensity and duration time via different immunization routes, the positive staining in all tissues was in the order of intramuscular injection group>nasal administration group > oral administration group. [ Conclusion ] The results demonstrated that chitosan as a polycationic gene carrier could promote the expression efficiency of DPV gC antigens in the vaccinated ducklings. Intramuscular injection was considered to be the best immunization routes to inoculated chitosan/pcDNA- DPV-gC gene vaccine.%[目的]以DPV gC基因疫苗(pcDNA-DPV-gC)为模型,采用复凝法制备壳聚耱/pcDNA-DPV-gC纳米微球,对其在雏鸭体内的抗原表达和分布进行初步研究.[方法]将壳聚糖/pcDNA-DPV-gC基因疫苗以肌注、滴鼻和口服3种途径免疫20日龄雏鸭,于免疫后不同时间点(4h、12h、1d、3d、5d、7d、2 w、4 w、6 w和10w)分别随机宰杀2只雏鸭,采集肝、脾、肺、肾、胰、脑、胸腺、哈氏腺、法氏囊、食道、十二指肠、盲肠和直肠,应用间接免疫组化检测DPV gC基因在雏鸭体内的抗原表达和分布. [结果]①肌注组免疫雏鸭1d,肝脏、法氏囊、十二指肠、盲肠和直肠检测到DPV gC蛋白;滴鼻组免疫雏鸭12h,肺脏出现阳性信号,1d哈氏腺和法氏囊检测到DPV gC蛋白;口服组免疫雏鸭12h,食道出现中等强度的阳性信号,1d法氏囊、十二指肠、盲肠和直肠检测到DPV gC蛋白;②在3种免疫途径中,肝脏、肺脏、法氏囊、哈氏腺、食道、十二指肠、盲肠和直肠是DPVgC抗原表达的主要器官;阳性信号主要在肝细胞、肺上皮细胞、法氏囊和哈氏腺淋巴细胞、食道上皮细胞和肠道粘膜上皮细胞及固有层细胞等部位;③不同免疫途径免疫的壳聚糖/pcDNA-DPV-gC基因疫苗在雏鸭体内的抗原表达量和持续时间的总体表达规律为:肌注组>滴鼻组>口服组.[结论]壳聚糖能促进DPV gC基因在雏鸭体内的表达和分布,肌肉注射是壳聚糖/pcDNA-DPV-gC基因疫苗首选的免疫方式.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号